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The B-lymphocyte lineage is a leading system for analyzing gene regulatory networks (GRNs) that
orchestrate distinct cell fate transitions. Upon antigen recognition, B cells can diversify their
immunoglobulin (Ig) repertoire via somatic hypermutation (SHM) and/or class switch DNA
recombination (CSR) before differentiating into antibody-secreting plasma cells. We construct a
mathematical model for a GRN underlying this developmental dynamic. The intensity of signaling
through the Ig receptor is shown to control the bimodal expression of a pivotal transcription factor,
IRF-4, which dictates B cell fate outcomes. Computational modeling coupled with experimental
analysis supports a model of ‘kinetic control’, in which B cell developmental trajectories pass
through an obligate transient state of variable duration that promotes diversification of the antibody
repertoire by SHM/CSR in direct response to antigens. More generally, this network motif could be
used to translate a morphogen gradient into developmental inductive events of varying time,
thereby enabling the specification of distinct cell fates.
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Introduction
Over the last decade, considerable progress has been made in
the combined experimental and theoretical analyses of regula-
tory networks that are utilized by cells to process information
about their environments and regulate their function (Alon,
2007). Much of this work has focused on gene regulatory
networks (GRNs) in unicellular organisms (Aurell et al, 2002;
Ozbudak et al, 2004; Santillan and Mackey, 2004; Acar et al,
2005; Suel et al, 2006). These studies have demonstrated that
certain network topologies (motifs) are conserved and appear
to have evolved to perform similar functions in a variety of
contexts (Milo et al, 2002). The cells ofmulticellular organisms
proceed through many developmental transitions and can
acquire a multitude of differentiation states, each associated
with a unique set of functions. The network topologies and
dynamics underlying these more complex developmental
programs are being intensively explored (Davidson, 2006).
Understanding metazoan GRNs from an integrated theoretical
and experimental perspective is of great interest given the
elaboration of cellular states that exhibit highly complex
spatial and temporal dynamics.
The mammalian immune system represents a powerful
system for exploring GRNs that regulate cellular differentiation
(Singh et al, 2005). These networks culminate in the
acquisition of effector functions for host defense against
pathogens. Immunoglobulin (Ig) molecules (antigen recep-
tors) are the hallmark of B lymphocytes and have a central role
in their effector functions. Whereas membrane Ig enables
antigen uptake and its presentation to T cells, secreted Ig
(antibody) functions in neutralization and phagocytosis of
pathogens. Upon antigen encounter, B cells can undergo an
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exceptional developmental dynamic involving diversification
of their antigen receptor (membrane Ig) by targeted somatic
hypermutation (SHM) of Ig genes and/or expression of distinct
Ig isotypes (IgM versus IgG, E, A) via class switch DNA
recombination (CSR) (Rajewsky, 1996) (Figure 1A). SHM-
mediated diversification of the initial Ig repertoire enables
affinity maturation by selection of mutations during the course
of the humoral response. The molecular processes of SHM and
CSR occur prior to terminal differentiation of B cells into Ig-
secreting plasma cells. It should be noted that whereas CSR
can occur during B cell responses that do not require
interaction with T cells, SHM occurs in the context of T cell-
dependent B cell responses within specialized structures
termed germinal centers (MacLennan et al, 2003). Despite
extensive characterization of B cell responses in the context of
distinct immunization and infection regimes, the molecular
circuits that regulate the extent and nature of Ig receptor
diversification by SHM and/or CSR upon antigen encounter
remain poorly understood.
CSR and SHM are dependent on the transient expression of
AID (Muramatsu et al, 2000), an activation-induced cytidine
deaminase that targets the C residue, predominantly at ‘WRC’
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Figure 1 Modeling B cell fate dynamics. (A) Cell fate dynamics that are considered to underlie the generation of effector B cells. Activated B cells can directly
differentiate into IgM-secreting plasma cells or undergo CSR/SHM before terminal differentiation. (B) GRN that orchestrates B cell fate dynamics. Genes specific for the
CSR/SHM state are shown in green, and those specific for the plasma-cell state are shown in red. Arrows denote activation, and barred lines denote repression. A dotted
line indicates that the regulatory interaction may be indirect. In the model, the expression of genes other than Pax5 and Bach2 is assumed to be contingent upon B cell
activation; Bcl-6 and Bach2 are treated as a single species. (C, D) Typical trajectories in the [Blimp-1]-[AID] plane of the core deterministic model (Equation (1)) with
parameters corresponding to the basic bistability (C) and kinetic-control scenarios (D). Expression coordinates for the indicated components are spaced at equal time
intervals. (E, F) Duration of CSR/SHM state as a function of initial IRF-4 production rate. The time spent in the CSR/SHM state decreases with initial IRF-4 production
rate (eI) in the kinetic-control scenario (F) but is insensitive to eI in the basic bistability scenario (E). A cell is considered to have entered the CSR/SHM state when its
Pax5 concentration is above 3/4 of the peak value of Pax5 (around 1.5) and to have exited when Blimp-1 concentration is greater than a threshold ([Blimp-1]¼3).
Shading indicates standard deviations arising from noise in the multiscale simulations.
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sequences. Coordinated AID catalyzed deamination at donor
and acceptor switch regions within the IgH locus followed by
double-strand DNA cleavage and non-homologous end joining
results in the functional juxtaposition of a given variable gene
segment with a new IgH constant region. In SHM, targeted
deamination of the Ig variable gene region by AID followed by
error-prone repair leads to the generation of new variants,
some of which may confer higher-affinity binding to antigen.
The state that enables CSR and SHM requires the transcrip-
tion factors Pax5, Bcl-6, Bach2 and IRF-4 (Dent et al, 1997;
Fukuda et al, 1997; Muto et al, 2010). Pax5 and IRF-4 regulate
the induction of the AID gene (Klein et al, 2006; Sciammas
et al, 2006; Tran et al, 2010). Pax5 additionally positively
regulates the expression of the Bach2 and Bcl-6 genes, the
products of which function to repress the plasma-cell-specific
program (Shaffer et al, 2000; Tunyaplin et al, 2004; Nera et al,
2006; Ochiai et al, 2006; Schebesta et al, 2007).Whereas Bach2
is required within extrafollicular as well as germinal center B
cells, Bcl-6 functions specifically in the latter context. Unlike
Pax5, Bcl-6 and Bach2, the transcription factor IRF-4 is also
required for the plasma-cell state (Klein et al, 2006; Sciammas
et al, 2006). This state is additionally dependent on a distinct
set of regulators that include Blimp-1 and Xbp1 (Shapiro-
Shelef et al, 2003; Sciammas and Davis, 2004; Shaffer et al,
2004). In addition to promoting plasma-cell differentiation,
Blimp-1 represses key components of the CSR/SHM program
(Pax5 and Bcl-6), thereby creating a mutual antagonism (Lin
et al, 2002; Shaffer et al, 2002; Kallies et al, 2004; Sciammas
and Davis, 2004; Cimmino et al, 2008). Although these
transcription factors have been individually characterized
and also assembled into a GRN (Sciammas et al, 2006)
(Figure 1B), it remains to be determined how their collective
interactions give rise to distinct developmental trajectories and
cell fates.
As noted above, IRF-4 promotes two mutually antagonistic
programs of B cell gene expression that underlie CSR/SHM or
plasma-cell differentiation (Klein et al, 2006; Sciammas et al,
2006). IRF-4 not only positively regulates the AID gene, but
also the gene encoding Blimp-1 (Sciammas et al, 2006). We
proposed that differing concentrations of IRF-4 regulate the
transition between the competing programs of gene expression
with low levels favoring CSR/SHM and higher levels inducing
plasma-cell differentiation (Sciammas et al, 2006). This
remains to be experimentally tested. While our earlier
results established the importance of IRF-4 for both fates, it
remained to be elucidated how IRF-4 enables the GRN to
modulate its response to signaling through the antigen or other
receptors, so as to control the extent and nature of Ig
diversification before differentiation of B cells into Ig-secreting
plasma cells. We now use computational modeling to analyze
the network architecture and then test its predictions
experimentally.
We demonstrate that B cell antigen receptor (BCR) signaling
initially induces IRF-4 expression in an antigen-dependent
manner, and this pattern resolves into a bimodal distribution
of cells with low and high IRF-4 levels. These differing levels of
IRF-4 promote B cell differentiation into Ig-switched and Ig-
secreting cells, respectively. Computational modeling is used
to contrast two scenarios that could underlie B cell fate
dynamics. In one case, the initial IRF-4 production rate
controls a binary choice between going to the CSR/SHM state
or to the plasma-cell state; the time spent in the CSR state is
relatively insensitive to the initial IRF-4 production rate
(herein called ‘basic bistability’). In the other case, IRF-4
drives all cells through a transient CSR/SHM state, but the
initial IRF-4 production rate sets its duration (‘kinetic control’).
To distinguish between these two scenarios experimentally, we
control IRF-4 expression levels via differential BCR signaling or
by using a novel inducible transgenic Irf4 allele. Gene
expression patterns corresponding with the two competing
developmental states as well as cellular fate outcomes are
quantitatively analyzed in response to varying IRF-4 concen-
trations. Importantly, we quantify the fraction of B cells that
pass through the CSR/SHM state by determining the frequency
of AID-dependent mutations experienced by individual cells.
Collectively, our data are consistent with the kinetic-control
model in which the initial IRF-4 production rate dictates the
duration of an obligate CSR/SHM state that activated B cells
transit through before differentiating into Ig-secreting plasma
cells. These results imply that IRF-4 serves as a sensor of
antigen receptor signaling to control the duration of CSR/SHM
and promote the exit of high-affinity B cells from the germinal
center. We propose that the novel network motif could be used
in other developmental contexts for translating a graded
inductive signal into discrete temporally regulated programs of
gene expression, thereby specifying cell fates.
Results
Architecture of GRN that regulates effector B cell
fate choice
The GRN that underlies the generation of effector B cells
(Figure 1B) centers on the mutual repression between
transcription factors of the plasma-cell program (Blimp-1
and IRF-4hi) (Shaffer et al, 2002; Kallies et al, 2004; Sciammas
and Davis, 2004; Sciammas et al, 2006; Teng et al, 2007) and
those needed for CSR/SHM (Pax5, Bcl-6, Bach2 and IRF-4lo)
(Shaffer et al, 2000; Tunyaplin et al, 2004; Nera et al, 2006;
Ochiai et al, 2006; Schebesta et al, 2007). Mutual repression is
a common strategy underlying exclusive realization of
competing binary outcomes (Laslo et al, 2006; Alon, 2007).
However, there are two crucial differences in the architecture
of the GRN here in comparison with ones that were previously
studied: (i) a single-regulator (IRF-4) activates genes on both
sides of the genetic switch and (ii) in addition to the mutual
repression, there is a positive feedback loop based on mutual
activation (Blimp-1 and IRF-4; Figure 1B) (Kallies et al, 2004;
Sciammas and Davis, 2004).
In this regard, it is important to note that the key positive
regulatory connection between IRF-4 and Blimp-1 (Sciammas
et al, 2006) was not supported by another study (Klein et al,
2006). To corroborate our earlier findings and validate the
GRN, we crossed a Blimp-1:GFP knock-in reporter allele
(Kallies et al, 2004) with the Irf4/ alleles. Splenic B cells
from these mice were stimulated with LPS or CD40L in
the presence of IL-4. These conditions efficiently induced
Blimp-1 expression in a large fraction of the cells and their
differentiation into Ig-secreting plasma cells. Whereas the
Blimp-1:GFP allele was strongly induced in Irf4þ / B cells,
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its activation was considerably impaired in Irf4–/– B cells
(Supplementary Figure S1). Thus, in combination with our
previous analyses and subsequent reports in the literature
(Shaffer et al, 2008), these data demonstrate that IRF-4
positively regulates Blimp-1 gene expression during plasma-
cell differentiation.
Mathematical modeling of B cell fate trajectories
The GRN interactions do not in themselves explain the
observed IRF-4 expression dynamics and the control of B cell
fate. To explore these issues, we translated the network into a
set of rate laws for the expression of the molecular species in
Figure 1B by standard means (see Materials and methods;
Supplementary information). Activation is treated as catalysis
of gene expression and repression as (non-competitive)
inhibition, and corresponding Michaelis–Menten-like forms
are used to represent the production of each species. We then
add degradation terms and noise, and integrate the resulting
equations to simulate the gene regulatory dynamics of
activated B cells (here, by ‘activated B cells’ we mean cells
that have been stimulated by antigen recognition through the
BCR, but have not yet transitioned to either the CSR/SHM or
plasma-cell state). In an activated B cell, AID and Blimp-1 are
not expressed to measurable extents, and their initial
concentrations and expression rates are thus set to zero in
the model (marked ‘initiation’ in Figure 1C and D); Bach2 and
Pax5 are expressed, and we set the initial rate of Pax5
production to be such that its concentration rises upon
activation (Wakatsuki et al, 1994) (data not shown). As Irf4
is an immediate early gene downstream of antigen receptor
signaling (Matsuyama et al, 1995), and its level of expression
correlates with cell fate (Sciammas et al, 2006), we examined
the dynamics of the model as a function of the initial IRF-4
production rate (the initial concentration of IRF-4 is set to
zero).
In general, the kinetic parameters for the various elementary
steps contributing to the gene regulatory dynamics have not
been measured. To limit the free parameters to a number that
can be exhaustively explored, we set the maximal rates of
activated expression (kx in Equation (1)), the rates of protein
degradation (b) and the binding affinities of the regulators
(Ka¼Kr) to be the same for as many species as allowed
capturing the known biological features. We then verified that
our conclusions were robust to non-uniform choices of the
parameters by randomizing them. The model revealed two
possibilities regarding the manner in which increasing IRF-4
production could regulate cell fate. In the first, IRF-4
production controls an initial decision between the plasma-
cell and CSR/SHM states (Figure 1C). Greater production of
IRF-4 favors the plasma-cell state. Importantly, exit from the
CSR/SHM state in this scenario is relatively insensitive to the
initial IRF-4 production rate (Figure 1E); the plasma-cell state
is irreversible owing to the positive feedback loop between
Blimp-1 and IRF-4. Thus, in this basic bistability scenario, IRF-
4 production modulates the cell fate decision, while having
little effect on its kinetics. In the second possibility, the kinetic-
control scenario, all cells proceed through the CSR/SHM state
with variable duration before differentiating into plasma cells
(Figure 1D). The main effect of raising IRF-4 production is to
reduce the average time that cells dwell in the CSR/SHM state
(Figure 1F). In this scenario, increases in the initial IRF-4
production rate diminish the likelihood that B cells have
sufficient time to undergo CSR/SHM. The mathematical basis
for the two scenarios is discussed further in Box 1.
In general, measurements on populations of cells can reflect
not only differentiation but also proliferation. To account for
both factors in making experimentally testable predictions, we
developed a multiscale simulation. We consider a population
of proliferating cells, in each of which the concentrations of the
molecules shown in Figure 1B evolve independently according
to the model described above. We assume that antigen is in
equilibrium with the BCR to set the extent of ligand binding,
and, in turn, the mean initial production rate of IRF-4 (normally
distributed). Based on the concentrations of AID and Blimp-1,
cells probabilistically undergo CSR/SHM and/or differentiation
into plasma cells (see Supplementary information). Simulations
based on either the basic bistability or kinetic-control scenarios
both predict that increasing the initial IRF-4 production rate
favors the generation of plasma cells at the expense of CSR/SHM
(Figure 2A and B).
To discriminate between the basic bistability and kinetic-
control scenarios, we used the multiscale model to predict the
mRNA dynamics for the genes in the network as a function of
time and the initial IRF-4 production rate (Supplementary
Figure S6). In the basic bistability scenario, higher IRF-4
production increases the likelihood that a cell transitions to the
plasma-cell state without visiting the CSR state. In contrast, for
the kinetic-control scenario, IRF-4 production governs the time
a cell spends in the CSR/SHM state. Thus, the two scenarios
can be distinguished by examining the peak mRNA expres-
sion levels of the antagonistic regulators (Bcl-6/Bach2 and
Blimp-1) as a function of the initial IRF-4 production rate
(Figure 2C and D). In the basic bistability scenario, the
curve for Bcl-6/Bach2 expression trends down and that for
Blimp-1 trends up (Figure 2C) because an increase in the
production rate of IRF-4 favors direct differentiation into
plasma cells without visiting the CSR/SHM state. In contrast,
for the kinetic-control scenario, the expression curve for
Bcl-6/Bach2 is flat (Figure 2D) because changes in IRF-4
production impact the duration rather than the peak levels
of gene expression associated with the CSR/SHM state
(see Supplementary Figure S8 for additional analysis of the
sensitivity of the Bcl-6/Bach2 gene expression curve with the
specific choice of parameters). In summary, although both
scenarios predict that increasing the initial IRF-4 production
rate favors the generation of plasma cells at the expense of
CSR/SHM, they differ fundamentally with respect to their
transcriptional dynamics.
Strength of BCR signaling determines the
dynamics of IRF-4 expression
With a view toward testing the mathematical modeling and
distinguishing between the above scenarios, we utilized B cells
from the B1-8i transgenic mouse, which expresses a rear-
ranged V187.2 VDJ gene segment knocked in to the Ig heavy
chain locus (Sonoda et al, 1997). This rearranged IgH allele
increases the precursor frequency of B cells that respond to
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nitrophenol (NP)-conjugated antigens. Splenic B1-8i B cells
were activated in vitro with NP(12)-Ficoll antigen; IRF-4
expression levels and cell division (CFSE dilution) were
monitored over time using flow cytometry (Figure 3A). IRF-4
was induced as early as 12 h following antigen stimulation
(data not shown) and exhibited a dose-dependent pattern of
expression in undivided cells (see day 1 distribution). Cell
division was accompanied by the generation of two stable IRF-
4-expressing populations, referred to as IRF-4lo and IRF-4hi
(see day 3 distribution).
We next measured IRF-4 levels in antigen-stimulated B1-8i B
cells as a function of antigen dose and avidity [NP(12)-versus
NP(109)-Ficoll] (Figure 3B). Notably, at day 1 of stimulation,
increased antigen concentration shifted the IRF-4 distribution
toward the higher expression state (Figure 3B; Supplementary
Figure S2). At later times (e.g. day 3), the distribution of cells in
the IRF-4lo and IRF-4hi states was similarly altered as a function
of antigen concentration. Since we had previously correlated
IRF-4hi-expressing cells with expression of the plasma-cell
marker Syndecan-1 (Sciammas et al, 2006), these data suggest
Box 1 Mathematical basis for the basic bistability and kinetic-control scenarios
Here, we qualitatively illustrate how different behaviors emerge from the GRN in Figure 1B depending on the choice of parameters. To
emphasize the generic nature of the behaviors, we use a simplified GRN in which an inductive signal or pivotal regulator (X) activates the
expression of two counter-acting components (Y and Z; see Warmflash and Dinner (2009) for a more quantitative discussion of this motif).
As indicated in the figure, different rates of X production result in different developmental trajectories as follows: (i) At low rates, the
system is bistable: there are two stable steady states (red and green circles) and the boundary (or tipping point) separating their basins
of attraction is determined by an unstable steady state (blue). The initial conditions indicated at the bottom left of the YZ plane are in the
basin of attraction of the green steady state, and trajectories flow to the green steady state in which Y represses Z. Initial conditions
further to the right (higher Z, not shown) could lead directly to the red steady state. (ii) The green stable steady state and the blue
unstable steady-state coalesce as X production increases; trajectories starting at the bottom left still flow to the green state, but small
perturbations cause them to continue to the red state. (iii) Trajectories follow the same flow pattern, but now there is a route out of the
region where the green and blue steady states came together (the ‘ghost’ of the stable state (Strogatz, 1994), dashed circle); because
the direction of the flow previously reversed at the blue steady state, the dynamics are slow in this region. All flows eventually lead to the
red steady state, in which Z represses Y. (iv) Qualitatively similar to (iii), but now the previous steady states have less impact on cell fate
dynamics (X production has changed more) and flow to the red steady state is faster; Z more strongly represses Y.Different choices of
parameters cause the threshold point in (ii), known as a reverse saddle-node bifurcation, to fall at different rates of X production relative
to the range that is accessed experimentally. In the basic bistability scenario, the bifurcation point is high compared with the range of
rates of X production, such that the behavior in (i) is always operative. This, together with choices of initial conditions that are poised at
the boundary between the basins of attraction of the two steady states, allows early partitioning of the developmental trajectories. In the
kinetic-control scenario, the bifurcation point is in or just below the range of rates of X production; as a result, the green stable state is
lost, but trajectories starting in the bottom left are still attracted to the corresponding pattern of gene expression and spend a finite time in
its vicinity as in (iii). A robust feature is that the time required to pass through the region of the transient state (which here permits AID
expression) decreases significantly as the controlling parameter (here, the initial IRF-4 production rate) is raised further (iv). It is of
course also theoretically possible that the bifurcation is well below the experimental range of rates of X production, but we exclude this
third scenario from further consideration as it implies in the present study that cells never have an opportunity for CSR, which is
inconsistent with the biology. Further analysis (Materials and methods, Supplementary information, Supplementary Figures S7–9, and
data not shown) shows that, because the basic bistability and kinetic-control scenarios differ primarily with respect to their early
dynamics, the parameters that most strongly impact whether one or the other is realized are those that strengthen the regulation of
Bcl-6/Bach2 by Pax5 (s and nC in Equation (1d), as well as the initial levels of Bcl-6/Bach2 and Pax5).
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Figure 2 Experimentally testable predictions for B cell fate dynamics. (A, B) Relative numbers of plasma cells (red) and Ig-switched cells (green) predicted by the
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that increased BCR signaling and, in turn, increased initial IRF-
4 expression correlates with enhanced plasma-cell generation
(see below for a more detailed analysis). A comparison of the
dose response of NP(12)-Ficoll with NP(109)-Ficoll revealed
that the higher avidity antigen shifted the IRF-4 distribution
toward the higher expression state at lower concentrations
(data not shown; Figure 3B). In summary, these data show that
BCR signal strength sets the initial pattern of IRF-4 expression,
which in turn dictates the frequencies of IRF-4lo and IRF-4hi
cells.
BCR signal strength determines cell fate outcome
Having established the relationship between BCR signaling
and IRF-4 expression levels, we sought to validate the
prediction common to both scenarios that increasing the
initial IRF-4 production rate favors the generation of plasma
cells at the expense of CSR. To this end, we analyzed the
outcome of B1-8i B cell differentiation as a function of antigen
dose or avidity. Purified splenic B1-8i cells were stimulated
with antigen, CD40 ligand and the cytokines interleukin-2, -4
and -5 and their differentiation was analyzed by comparing
the frequency of plasmablast (Syndecan-1-expressing) or
switched (surface IgG1-expressing) cells by flow cytometry
(Figure 4A) and ELISpot (Supplementary Figure S3). Strik-
ingly, higher antigen concentrations led to an increase in the
frequency of Syndecan-1-expressing plasma cells, and that
increase occurred at the expense of CSR to IgG1. As predicted,
stimulation of B1-8i cells with higher avidity antigen (NP(109)-
Ficoll) resulted in increased generation of plasmablasts and a
corresponding decrease in the frequency of cells that had
undergone CSR (Figure 4A). Thus, as predicted by the
modeling (Figure 2A and B), the dynamic patterns of IRF-4
expression, which vary with the intensity of BCR signaling,
correlate with the modulation of B cell fate choice.
Care must be taken in interpreting cell frequency data in the
context of a population of cells undergoing division; therefore,
we enumerated absolute numbers of plasmablasts as well as
cells that had undergone CSR to IgG1 as a function of NP(12)-
Ficoll dose on day 3. Consistent with the frequency data, there
is a dramatic increase in the absolute numbers of plasma cells
and a decrease in CSR (Supplementary Figure S3). We note,
however, that the increase in plasma-cell numbers is steeper
than the decline in cells that have undergone CSR to IgG1,
suggesting that IRF-4 may exert effects on cell growth in
addition to differentiation. To address this possibility, we
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Figure 4 IRF-4 transduces BCR signal strength to control B cell fate. Purified splenic B cells from NP-specific B1-8i heavy chain knock-in mice were stimulated with
NP(12)-Ficoll in the presence of interleukin-2, -4, -5 and soluble CD40L. Serial 10-fold dilutions of NP-Ficoll were used with an initial concentration of 0.01 ng/ml. (A)
Differentiated cells were analyzed at day 4 and all flow cytometry plots are shown in relation to cell division (CFSE). The frequencies of plasmablasts (Syndecan-1þ ) and
IgG1 class-switched cells are shown as a function of increasing antigen concentration. (B) BCR signal strength dictates B cell fate dynamics by modulating changes in
the expression levels of key components of the GRN. RNA was isolated from B cells activated as described above on days 1, 2 and 3. Indicated transcripts were
measured by quantitative RT–PCR; transcripts were normalized to Oct1 and used to calculate relative expression. Shown is the average expression from two
independent experiments, with results for each gene in turn normalized by its highest expression across all conditions. (C) Peak levels of Bach2 (green) and Blimp-1
(red) expression from (B) as a function of antigen concentration.
A network architecture orchestrating B cell fate
R Sciammas et al
& 2011 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2011 7
quantitatively analyzed cell division rates (Supplementary
information; Supplementary Table S2). Although the rate of
cell division of IRF-4hi cells was two- to three-fold higher than
that of their IRF-4lo counterparts, simulations based on these
rates yielded results similar to those in Figure 2A and B
(Supplementary Figure S10). Taken together, these analyses
support the idea that the GRN in Figure 1B functions to
translate BCR signal strength into cell fate choice.
Gene expression dynamics support the
kinetic-control scenario
While the two scenarios suggested by the modeling lead to
similar predictions for cellular fates, they differ in their
predictions for the expression patterns of the components of
the network (Figure 2). Thus, we analyzed the RNAexpression
patterns of the network components in B1-8i cells by
quantitative RT–PCR as a function of time and antigen
concentration (Figure 4B) and avidity (data not shown).
Consistent with the outcome of differentiation, increasing BCR
signal strength results in a strong upregulation of the plasma-
cell program component Blimp-1. With regard to the model
predictions, we see that AID is induced to similar levels at all
BCR signal intensities (see day 2 expression levels), but then
decreases at day 3 in a manner strongly dependent on BCR
signal intensity. These dynamics reflect uniform peak levels of
CSR regulators (Bach2 and Pax5 at day 1) over a wide range of
NP concentrations (Figure 4B and C) and are consistent with
the kinetic-control scenario, but not the basic bistability
scenario (compare Figure 4C with Figure 2C and D). In other
words, the CSR/SHM pattern of gene expression appears to
reflect an obligate developmental state, and the role of IRF-4 is
to control its duration.
We additionally fit the core gene regulatorymodel (Equation
(1)) to the mRNA data, as detailed in the Supplementary
information. Given the minimal nature of the model, the
expression patterns are reproduced with reasonable accuracy
(Supplementary Figure S11). Although the data are not
sufficient to constrain the parameters to unique values, in all
cases, the resulting bifurcation points, which determine the
model behavior as described in Box 1, are within the range of
signals assumed, as in the kinetic control, but not the basic
bistability scenario. This quantitative result, which is based on
the complete mRNA data rather than only the peak levels,
corroborates the qualitative predictions in Figure 2.
Finally, we compared the stochastic multiscale simulation
behavior with the flow cytometry data in Figure 3B (Supple-
mentary Figure S12). In both scenarios, the variations in signal
are translated to shifts in the IRF-4lo and IRF-4hi populations by
the positive feedback resulting from mutual repression
between Bcl-6/Bach2 and Blimp-1 and mutual activation
between IRF-4 and Blimp-1 (Figure 1B). However, there are
significant numbers of cells with IRF-4 levels between the IRF-
4lo and IRF-4hi populations in Figure 3B, and this pattern is
again better captured by the kinetic-control scenario (Supple-
mentary Figure S12). This scenario exhibits a greater number
of such cells because they correspond to cells that pass through
the CSR/SHM state rather than directly differentiating to the
plasma-cell state. We thus interpret the data in Figure 3B to
lend support to the idea that a substantial fraction of cells pass
through the CSR/SHM state, and we sought a means to
examine this proposition directly.
Mutational analysis of IgH switch regions
demonstrates that IgM-secreting plasma
cells transiently visit a CSR/SHM state
A complementary means of evaluating the model scenarios
would be to quantify the fraction of cells that pass through the
CSR/SHM state. We focus our analysis on AID-dependent
mutations associated with CSR as under the in vitro condi-
tions, the frequency of SHM is low. Clearly, all IgG1þ cells pass
through the CSR/SHM state; the question is how many IgMþ
plasmablasts cells do as well. In a bistability scenario in
which CSR/SHM is effectively coupled to AID induction, this
fraction would be negligible, whereas in the kinetic-control
scenariowith probabilistic opportunity for CSR/SHM, it would
be appreciable and only limited by the approach used to detect
the state. We thus sought to quantify the fraction of IgMþ
plasmablasts cells that pass through the CSR/SHM state.
The Sm region is known to accumulate AID-dependent
mutations following B cell activation (Petersen et al, 2001;
Nagaoka et al, 2002; Xue et al, 2006). We purified wild-type B
cells that were stimulated with CD40L and IL-4, and sorted
them based on IgM and Syndecan-1 or IgG1 expression to
screen for terminally differentiated cells that induced AID and
had or had not undergone functional CSR (Supplementary
Figure S4). Genomic DNA was purified from the sorted cells
and used to generate PCR products of the Sm region for
subsequent cloning and sequencing.
Analysis of the sequences from individual IgMþ , Syndecan-
1-expressing plasmablasts revealed the presence of mutations
in the Sm region, the majority of which were C to T transitions
involving the AID hotspot motif WRC (Table I; Supplementary
Figure S4). Importantly, this spectrum of mutations was
dependent on AID, as similarly sorted cells from Aicda/
cells exhibited no such mutations. The background mutations
likely reflect Taq polymerase error. A total of 7% of IgMþ
plasmablasts have AID-dependent mutations; given that only
21% of IgG1þ cells have AID-dependent mutations, we estimate
the fraction of IgMþ cells passing through the CSR/SHM state
to be 33% (7% normalized by 21%). This is a lower bound
since we expect that sorting for cells that have not switched
experimentally selects for a population that expressed AID for
a shorter time. These single-cell data substantiate the kinetic-
control scenario in the sense that a large fraction of IgMþ
plasma cells (cells that never completed CSR) followed a
developmental trajectory through a state of transient AID
activity accompanied by a probabilistic opportunity for
CSR/SHM prior to terminal differentiation.
Induced levels of IRF-4 dictate B cell fate dynamics
To directly test a causal role for Irf4 expression levels in
controlling B cell fate, we developed an experimental system
that would afford control of Irf4 expression in naive primary B
cells.We constructed a tet-inducible system (Beard et al, 2006)
as follows; a cassette containing a tetracycline-regulatable Irf4
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transgene was recombined at a neutral, defined position
downstream of the CollagenA1 locus using Flp-mediated
homologous recombination in ES cells (Supplementary Figure
S5). These cells were engineered to express the tetracycline-
dependent transactivator (M2rtTA) from the Rosa26 locus.
Suitable ES cell clones (Supplementary Figure S5) were used to
transmit the tet-regulatable Irf4 allele through the germline.
When crossed to the Irf4þ / background, both endogenous
and transgene expression of Irf4 combine to attain higher than
wild-type expression levels. In contrast, when crossed to the
Irf4/ background, Irf4 gene expression can be uncoupled
from BCR as well as CD40 signaling, and a lower range of
expression of IRF-4 can be induced and maintained because
the transgene is the sole source. In this way, the inducible-Irf4
allele enables a wide dynamic range of IRF-4 production.
We first tested the dynamics of alternate cell fate choice as a
consequence of inducing IRF-4 expression in cells containing
an endogenous wild-type Irf4 allele. We purified B cells from
the Irf4-inducible mouse (on the Irf4þ / background) and
stimulated them with CD40L and IL-4 in the presence of
varying concentrations of a high-affinity analog of tetracycline,
doxycycline (DOX). Strikingly, increasing Irf4 expression levels
induced by DOX resulted in markedly enhanced plasma-cell
generation that occurred at the expense of CSR (Figure 5A;
compare with Supplementary Figure S12). The lower panel
shows the amount of IRF-4 expression achieved by DOX at
day 3 of differentiation. We next measured the effects of
exogenously controlled Irf4 expression on the dynamics of
network components (Figure 5B and C). At early time points,
Pax5, Bach2 and AID are all induced to comparable levels
regardless of DOX concentration, consistent with the kinetic-
control scenario. Downregulation of the CSR factors occurs
only as Blimp-1 levels rise at later time points.
We also tested the effects of Irf4 levels on B cell fate
dynamics in the absence of endogenous Irf4 expression. DOX-
inducible IRF-4 was capable of complementing the Irf4 genetic
deficiency (Figure 6A; compare with Supplementary Figure
S13). In the absence of endogenous Irf4, we note that the
extent of CSR initially increases and then decreases with dose.
In the model, the increase results from the fact that IRF-4 is
needed for cells to initiate CSR, while the decrease results from
the kinetic-control mechanism. We note that the magnitude of
the decrease in CSR frequency is less in Irf4/ cells than Irf4þ /
cells, likely due to subtle differences in Irf4 expression levels
that were achieved in the two experimental conditions. The
expression dynamics mirror those obtained in the presence of
endogenous Irf4, although the fold change in Blimp-1 at later
times is much more dramatic because IRF-4 is required for its
expression. Importantly, the peak expression of CSR/SHM-
associated genes is the same across DOX conditions (Figure 6B
and C). Collectively, these data confirm that varying IRF-4
levels is sufficient to control the duration of the CSR/SHM state
and in turn the cell fate dynamics of activated B cells, and
the associated gene expression patterns provide additional
support for the kinetic-control scenario.
Discussion
Our results strongly suggest that the levels of BCR-induced IRF-
4 expression control the duration of an obligate CSR/SHM state
that enables B cell diversification before their terminal
differentiation into plasma cells. We have shown that (i) BCR
signal strength sets the initial IRF-4 concentration and (ii) the
GRN architecture enables sensing IRF-4 concentration to
regulate the extent of CSR prior to plasma-cell differentiation.
Evidence for the transient CSR/SHM state is corroborated
by both patterns of gene expression and the presence of
AID-dependent mutations in non-switched plasmablasts. We
note that our mutation data are consistent with recent in vivo
observations that IgM-expressing memory cells have experi-
enced AID activity (Dogan et al, 2009). Given that Bach2
expression was the most sensitive discriminator between the
basic bistability and the kinetic-control scenarios, it is
interesting to note that Muto et al (2010) recently showed
that Bach2 promotes CSR indirectly by repressing Blimp-1,
and they proposed that this regulatory interaction functions
as a time delay to enable CSR/SHM before plasma-cell
differentiation.
Given that AID is required for CSR/SHM and is regulated by
IRF-4, we propose that BCR signal strength sets the duration of
SHM in vivo by dictating the induced concentration of IRF-4.
Thus, a low-affinity BCR would induce a lower concentration
of IRF-4 upon antigen binding and sustain AID expression for a
longer duration, thereby increasing the likelihood of acquiring
mutations in variable regions of Ig loci that confer higher
Table I Analysis of AID-dependent mutations in sorted B cells
Exp. Cell population Mutated
nucleotides
Total
nucleotides
Mutation
frequencya
Mutated
clones
Total
clones
C to T transtions at
AID motif (WRC)
1 IgM PC (Aicda/) 1 46 373 0.00002 1 47 0
2 IgM PC (Aicda/) 3 41 954 0.00007 3 47 0
(sum) 4 88 327 0.00005 4 89 0
1 IgM PC (WT) 3 45102 0.00007 3 46 3
2 IgM PC (WT) 8 67 209 0.00012 5 52 4
(sum) 11 112 311 0.00010 8 98 7
1 IgG (WT) 13 44 631 0.00029 12 45 9
2 IgG (WT) 19 52 441 0.00036 16 48 11
(sum) 32 97072 0.00033 28 93 20
aNumbers shown in the sum lines are averages.
The frequency of mutations as a function of total bases sequenced in the Sm switch region and the frequency of mutated clones are indicated. The mutations that
represent C to T transitions within the AID motif (WRC) are enumerated in the right column. Results are from two independent experiments.
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affinity. The higher-affinity BCR would then induce higher
levels of IRF-4 expression and a qualitative change in the
dynamics of the GRN that would terminate AID expression and
the germinal center program and cause the activated B cell to
undergo plasma-cell differentiation (Figure 1A). This proposal
does not preclude the possibility that there is an additional
checkpoint, whereby follicular T helper cells ‘license’ high-
affinity B cells to exit the germinal center (Allen et al, 2007); in
this scenario, a T cell-derived signal could be integrated with
one emanating from the BCR to regulate overall IRF-4
concentration.
Our findings suggest a molecular explanation for the
changing nature of B cell responses in BCR transgenic mice
immunized with cognate antigens of differing affinity or
avidity (O’Connor et al, 2006; Paus et al, 2006; Phan et al,
2006; Fink et al, 2007). In these experiments, increasing
antigen affinity promotes the robust generation of IgM-
secreting plasma cells. The germinal center response is either
diminished or unaffected. We propose that these cell fate
dynamics result from strongly responding B cells that rapidly
accumulate high levels of IRF-4 and differentiate into IgM-
secreting plasma cells. Weakly responding B cells that induce
lower levels of IRF-4 may preferentially undergo a germinal
center response. Consistent with our proposed role for IRF-4, it
was recently shown that during a germinal center response,
high-affinity transgenic B cells recognizing hen egg lysozyme
are actively selected to become plasma cells (Phan et al, 2006).
While earlier studies (Shih et al, 2002a, b) reached a different
conclusion to that of Brink and co-workers (O’Connor et al,
2006; Paus et al, 2006; Phan et al, 2006; Fink et al, 2007), the
former analysis was performed over a narrower range of BCR
affinity (Tarlinton, 2008). Our results provide a molecular
framework for understanding B cell fate dynamics, which
balance the competing demands for Ig CSR/SHM with the
secretion of antibodies during humoral immune responses.
In fact, extension of our cellular multiscale stochastic
simulations to model in vivo plasma-cell and germinal center
responses (Supplementary information; Supplementary
Figure S14) shows that the network dynamics described here
are sufficient to account for the observations reported in
immunized BCR transgenic mice (O’Connor et al, 2006; Paus
et al, 2006) (Supplementary Figure S15). We note that while
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Figure 5 Super-induction of IRF-4 regulates B cell fate dynamics in a manner predicted by the modeling. (A) Purified splenic B cells of the indicated genotype
(Irf4þ /ColA1Irf4/Irf4Rosa26þ /M2rtTA) were stimulated with CD40L and IL-4 in the presence of varying concentrations of DOX (6.4–250 ng/ml). The frequencies of IgG1
class-switched cells and of Syndecan-1þ plasmablasts were determined at day 4 of activation, relative to cell division (CFSE dilution). The expression of IRF-4 as a
function of DOX was monitored by flow cytometry. The average frequencies from three experiments is shown along with s.e.m. (B, C) Induction of IRF-4 expression by
DOX results in changes in the expression levels of key components of the GRN. RNA was isolated and analyzed as described in Figure 4.
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models of B cell fate dynamics (Kleinstein and Singh, 2001;
Hawkins et al, 2007; Figge et al, 2008) were developed
previously, to the best of our knowledge, they were wholly
cellular in nature and did not link dynamic behavior to an
underlying GRN, as we do here. By evaluating the cell
autonomous capacity for differentiation, we have derived a
‘core’ module that operates, likely in cooperation with
additional factors in physiological contexts (such as differ-
ential co-receptor signaling and cell competition), to control
effector B cell fate dynamics.
The ability of IRF-4 to coordinate the two competing
patterns of gene expression is a direct consequence of the
network architecture (Box 1). When a determinant represses
one side of a mutual repression while activating the other, it is
termed ‘coherent’ (i.e. the two actions reinforce each other)
and its effect is to irreversibly express one set of genes at the
expense of another (Alon, 2007). Because the key feature that
allows IRF-4 to coordinate the two competing states of gene
expression in a temporal manner is that it simultaneously but
asymmetrically activates both sides of a bistable mutual
repression (i.e. the two actions antagonize each other), we
term it ‘incoherent’ (see Goentoro et al (2009) for an analogous
use in reference to a different regulatory motif). Here, we
showed how an incoherent architecture can give rise to both
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Figure 6 Inducible expression of IRF-4 is sufficient to regulate B cell fate in a manner predicted by the modeling. (A) Cell fate of purified splenic B cells of the indicated
genotype (Irf4/ColA1Irf4/Irf4Rosa26þ /M2rtTA) were enumerated as in Figure 5A. (B, C) Expression levels of key components of the GRN as a function of IRF-4
induction as in Figure 5B and C.
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basic bistability and kinetic-control behaviors depending on
the parameters, and we identified means to distinguish
between these competing scenarios. A related motif was
proposed to enable an activin morphogen gradient to induce
alternate states of gene expression for spatial patterning of the
Xenopus embryo in amanner analogous to the basic bistability
scenario discussed (Saka and Smith, 2007). An incoherent
structure that gives rise to dynamics more akin to the ghost
attraction is the GRN governing the transient acquisition of
competence for DNA uptake by Bacillus subtilis in response to
nutrient limitation (Suel et al, 2006, 2007). This response is
controlled by a factor that positively regulates expression of its
own gene and represses a gene encoding an inhibitor of its
degradation. The incoherent structure of the network enables
transient expression of the genes associated with competence
before returning the cells to the original vegetative state.
Recently, an incoherent feed forward loop was also suggested
to give rise to a transient pulse of expression of a glucose
transporter in yeast (Kuttykrishnan et al, 2010). To the best of
our knowledge, our study is the first to provide experimental
evidence for a network structure that enables a cell to sense an
environmental or developmental signal and transiently realize
a pattern of gene expression that promotes cellular diversifica-
tion prior to realization of a terminally differentiated state.
In the context of antigen-specific B cells, transient AID
catalyzed CSR/SHM gives rise to a diverse repertoire of plasma
cells.We speculate that a similar developmental strategy could
enable cellular diversification for biological advantage in other
contexts. Indeed, the competence GRN discussed above
exhibits substantial variation in the period allowing DNA
uptake (Suel et al, 2007). Engineered counterparts of this
circuit show less variation, suggesting that the natural one is
optimized for enhancing cellular diversification resulting from
DNA uptake. The discovery that diversity generating retro-
elements are widespread in bacterial genomes (Medhekar and
Miller, 2007) suggests that cellular diversification could be a
general feature of adaptive responses, and it will be interesting
to determine whether the extent of mutation in these systems
is also regulated by transient patterns of gene expression that
are of variable duration.
To the best of our knowledge, the mechanism of kinetic
control is novel, and it could have important implications for a
fundamental process in developmental biology, namely the
sensing of a morphogen gradient. In this process, a spatially
graded inductive signal is used to instruct a uniform field of
progenitors to adopt distinct cell fates based on concentration
of the morphogen at a given position along the gradient. The
specification of two distinct cell fates based on low versus high
concentrations of the morphogen can be readily understood in
molecular terms based on differential affinity or accessibility
of target genes that are activated by a morphogen-induced
transcription factor. However, this mechanism would require
an ever increasing number of distinct transcription factor
occupancy states to translate the continuously varying
concentration of the morphogen into a large set of cell fates.
In contrast, the GRN architecture described here enables the
conversion of the spatial information manifest in the morpho-
gen gradient into transient developmental states of continu-
ously varying duration. If such developmental states are in
turn based on successive layers of time-dependent gene
expression programs, then one can generate a large set of cell
fates simply by varying the timing of exit from the transient
inductive state and overt differentiation.
Materials and methods
Core computational model
Because the qualitative but not quantitative features of the regulatory
network are known, we use a common generic form for the rate laws
(Supplementary information), as we did to model development of
myeloid lineages previously (Laslo et al, 2006). Denoting the
concentrations of IRF-4, Blimp-1, Pax5, Bcl-6/Bach2 and AID by I, B,
P, C and A, respectively, Figure 1B translates to the equations
dI
dt
¼ eI þ kIB
nI
KnIa þ BnI
 
 bI ð1aÞ
dB
dt
¼ kBI
nB
KnBa þ InB
 
Knrr
Knrr þ Cnr  bB ð1bÞ
dP
dt
¼ ePK
nr
r
Knrr þ Bnr  bP ð1cÞ
dC
dt
¼ skCP
nC
ðsKaÞnC þ PnC
 
Knrr
Knrr þ Inr þ Bnr  bC ð1dÞ
dA
dt
¼ skAIP
nA
ðsKaÞnAþ1 þ IPnA
 !
 bA ð1eÞ
where kx (for x ¼ I, B, P, C and A) is the maximum rate of protein
production stimulated by an activator, Ka and Kr are the half saturation
constants for activation and repression, b is the rate of protein
degradation, nx and nr are Hill coefficients for activation and
repression and ex is the rate of synthesizing x in the absence of
activator. The ex terms are included to avoid extending the network to
events that are upstream of the species considered. In Equation (1),
ex¼0 for all species other than Pax5 and IRF-4 (see further discussion
below). As noted in the Supplementary information, a slightly
modified form for the rate of AID expression is required to incorporate
synergistic activation. The variable s is a scale factor that allows for
changing theMichaelis constants for the CSR regulators, while keeping
their overall level of expression relatively constant (see below). We
add to the equation for dx/dt a stochastic contribution that scales as
x1/2 as is typically expected for intrinsic noise.
Both the basic bistability and kinetic-control scenarios described
above can be simulated using this set of equations with different
parameters. The kinetic-control scenario requires only that the initial
conditions representing an activated B cell are closer to the CSR state
than the plasma-cell state, allowing each cell to initially adopt a CSR
pattern of expression. Because the activated B cell and CSR states share
molecular components (Pax5 and Bcl-6/Bach2 are expressed in both),
this is true for the majority of parameter combinations, and we choose
generic ones here. On the other hand, for IRF-4 to control the initial
partitioning between cell fates, as in the basic bistability scenario, the
regulation of the CSR genes must be strongly cooperative, and the
initial conditions must not be strongly biased toward either state. To
obtain these features, we set the Michaelis constants and Hill
coefficients for the activation of the CSR genes AID and Bcl-6/Bach2
sufficiently high that they are relatively insensitive to the amount of
Pax5 expressed in activated B cells. Specifically, we increase s, nC and
nA in Equation (1d) and (1e). See Table II for parameter values
employed.
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Multiscale simulation
To understand the consequences of the dynamics discussed above for
the populations of switched and antibody-secreting cells, we
performed multiscale stochastic simulations. In these simulations,
we begin with a population of 10 cells, each of which is in a state
corresponding to a naive B cell. The evolution of molecular
populations in each cell was generated using the model described
above. In addition to these dynamics, we also simulated cellular-level
events: division, death, class switching and differentiation into a
plasma cell. These events and the parameters associatedwith them are
detailed in Supplementary Table S1. Each such event was treated as a
first order process and was coupled to the fluctuating molecular
populations as follows: (1) A cell was assigned a probability per cell
division to undergo CSR that is proportional to its AID concentration.
(2) A cell with a Blimp-1 concentration greater than a threshold
concentration was assumed to have differentiated into a plasma cell.
Additional details concerning the specificmeans bywhichwemodeled
signaling aswell as sensitivity analyses are given in the Supplementary
information; Supplementary Figures S16–18.
Mice
The use and genotyping of the Irf4/ mice has been previously
described (Sciammas et al, 2006). The B1-8i knock-in mice were a
generous gift of K Rajewsky (Sonoda et al, 1997). The Blimp-1þ /GFP
mice were provided by S Nutt (WEHI) (Kallies et al, 2004). Aicda/
mice were provided by H Huang (University of Chicago) (Muramatsu
et al, 2000).Micewere housed in specific pathogen-free conditions and
were used and maintained in accordance of the Institutional Animal
Care and Use Committee guidelines.
The Irf4-inducible mice were generated based on the strategy
described by Beard et al (2006). Briefly, the Irf4 cDNAwas blunt-end
cloned into the EcoRI site present in the pBS31 flp-in vector. Next, this
vector was cotransfected with an FLPe expression vector into KH2 ES
cells. KH2 ES cells had been previously engineered to incorporate frt
sites and a defective hygromycin resistance gene in the CollagenA1
locus that would be complemented by successful targeting. In all, 9 of
10 hygromycin resistant clones were properly targeted as judged by
Southern blotting using a 30-probe specific to the ColA1 locus. Clone
O2 was chosen for further analysis and used to generate chimeric mice
by blastocyst injection. Chimeric mice were then backcrossed to the
C57Bl/6 background and to the Irf4-null allele.
Cells and culture conditions
Splenic B cells were isolated by sequential hypotonic lysis and
magnetic bead separation. Briefly, a single-cell suspension of spleen
cells was treated with Tris-buffered ammonium chloride to lyse red
blood cells and then a negative selection, bead-based immunopur-
ification strategy was employed that depletes T, NK and macrophage
cells using a cocktail of biotinylated antibodies specific for CD4, CD8,
CD3, CD49b, Gr1, CD11b, Ter119 (BD Biosciences) and adsorption to
Streptavidin microbeads (Miltenyi Biotec Inc.). The unbound cells
(typically490% B220 positive) were washed and placed into culture
at cell densities ranging between 0.25 and 0.5106 cells/ml,
depending on the experiment. For CFSE labeling, the isolated B cells
were washed with PBS and loaded with 1.5mM CFSE (Molecular
Probes) prior to culturing. Cells were stimulated with recombinant
human IL-2 (Roche) 100U/ml, recombinant murine IL-4 (R&D
Systems) 5 ng/ml, recombinant mouse IL-5 (R&D Systems) 1.5 ng/
ml, as indicated. CD40L membranes were prepared from insect cells
and used at 0.1mg/ml. NP(12)- and NP(109)-Ficoll were obtained from
BioSearch Technologies Inc. used at concentrations ranging from 0.01
to 0.00001 ng/ml.
Flow cytometry
Cells were washed in staining buffer, PBS containing BSA (0.5%, w/v)
and sodium azide (0.05%, w/v) and blocked with anti-FcR (clone
2.4G2) hybridoma supernatant. Cells were stained with biotin- or
fluorochrome-coupled antibodies in staining buffer using standard
procedures. Anti-mouse antibodies specific for Syndecan-1, IgG1 and
isotype controls were purchased fromBDPharmingen. Dead cells were
excluded from the analysis using DAPI (Molecular Probes). Flow
cytometric datawere processed using FlowJo software (Tree Star, Inc.).
Intracellular detection of IRF-4 was performed fixing cells with 1%
(w/v) paraformaldehyde for 10min and then permeabilized in staining
buffer containing 0.03% (w/v) saponin (Sigma). Staining buffer
containing 0.3% Saponin was used to incubate the cells with a
polyclonal goat anti-IRF-4 or normal goat IgG (Santa Cruz Biotechno-
logy) in the presence of 5% (v/v) donkey serum. Labeling was detected
using a Cy5-coupled donkey anti-goat (Jackson Immunoresearch).
Mutational analysis of Sl switch regions
Cells prepared as described above were sorted on day 4 of
differentiation based on IgM, IgG1 and Syndecan-1 into two subsets
(i) IgMþ plasmablasts: IgMþ , IgG1, Syndecan-1þ and (ii) IgG1-
switched cells: IgM, IgG1þ , Syndecan-1. Genomic DNA was
purified and used as a template for PCR using the M2 primers and
Pfu turbo polymerase as described (Xue et al, 2006). The PCR product
was purified using gel electrophoresis cloned into the PCR4 Blunt-
TOPO vector (Invitrogen) for DNA sequencing.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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